Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Tobias Boettler,Philip N. Newsome,Mario U. Mondelli,Mojca Maticic,Elisa Cordero,Markus Cornberg,Thomas Berg

DOI: https://doi.org/10.1016/j.jhepr.2020.100113

IF: 9.917

2020-06-01

JHEP Reports

Abstract:The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.